15
Participants
Start Date
November 30, 2015
Primary Completion Date
October 31, 2016
Study Completion Date
July 31, 2018
sibling umbilical cord blood
All subjects will receive a single infusion of allogeneic sibling cord blood. The first six subjects will receive cord blood cells from an HLA-matched sibling. The following 9 subjects will receive cord blood cells from an HLA-mismatched (≥3/6 match) or matched sibling. Six of the 15 subjects must be treated with haplo-identical sibling CB. Duration of study participation will be six months from the time of CB infusion.
Duke University Medical Center, Durham
Joanne Kurtzberg, MD
OTHER